Stocks DOLE Financial statements
Financial statementsDole plc financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Dole plc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 4,167 | 4,346 | 5,944 | 8,024 | 8,245 | 8,475 | 9,173 |
| Cost of revenue | 3,864 | 4,012 | 5,600 | 7,425 | 7,551 | 7,758 | 8,459 |
| Gross profit | 302 | 334 | 344 | 600 | 694 | 718 | 714 |
| Research and development | 0 | 0 | 3.8 | 9.2 | 9 | 8.9 | 9.2 |
| Selling, general and administrative | 254 | 265 | 323 | 436 | 474 | 474 | 495 |
| Selling and marketing | 5.8 | 5.3 | 10.6 | 17.8 | 17.9 | 19.5 | 20.1 |
| Operating income | 47.6 | 67.1 | -8.69 | 175 | 272 | 281 | 223 |
| Interest expense | 12 | 10.5 | 25 | 56.4 | 81.1 | 72.3 | 66.5 |
| Interest income | 3.08 | 2.6 | 3.81 | 6.41 | 10.1 | 10.7 | 13.4 |
| Other non-operating income | 4.14 | -0.12 | 8.44 | 10.6 | 4.8 | 20.6 | -1.57 |
| Pre-tax income | 42.8 | 59.1 | -21.4 | 136 | 206 | 240 | 168 |
| Income tax | 10.3 | 18.1 | -11 | -25.6 | 43.6 | 75.6 | 71 |
| Income from continuing operations | 13.3 | 143 | 146 | 154 | 97.3 | ||
| Net income to minority interests | 14.3 | 18.8 | 24.2 | 25.3 | 31.6 | 17.9 | 30.7 |
| Net income | 55.1 | 52.5 | -7.22 | 86.5 | 124 | 126 | 51.3 |
| EBITDA | 82 | 103 | 56.8 | 285 | 376 | 379 | 336 |
| EPS, basic | 0.99 | 0.95 | -0.10 | 0.91 | 1.31 | 1.32 | 0.54 |
| EPS, diluted | 0.99 | 0.94 | -0.10 | 0.91 | 1.30 | 1.32 | 0.53 |
| Shares, basic (weighted) | 55.5 | 55.5 | 72.2 | 94.9 | 94.9 | 95 | 95.1 |
| Shares, diluted (weighted) | 55.6 | 55.6 | 72.4 | 94.9 | 95.1 | 95.5 | 95.9 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 130 | 161 | 251 | 229 | 276 | 330 | 268 |
| Short-term investments | 0 | 6.12 | 5.37 | 5.9 | 6.02 | 6.42 | |
| Receivables | 362 | 719 | 610 | 538 | 474 | 540 | |
| Inventory | 141 | 411 | 394 | 379 | 430 | 509 | |
| Other current assets | 2.94 | 11 | 15 | 17.4 | 15.1 | 17.9 | |
| Total current assets | 730 | 1,641 | 1,605 | 1,921 | 1,838 | 1,752 | |
| Property, plant and equipment | 220 | 1,431 | 1,116 | 1,102 | 1,120 | 1,082 | |
| Lease right-of-use assets | 140 | 369 | 294 | 340 | 342 | 371 | |
| Goodwill | 221 | 234 | 511 | 497 | 513 | 430 | 434 |
| Intangible assets | 78.6 | 65.6 | 368 | 357 | 348 | 332 | 325 |
| Long-term investments | 16.5 | 13.8 | |||||
| Other non-current assets | 30.5 | 98.9 | 142 | 109 | 113 | 134 | |
| Total assets | 1,886 | 4,668 | 4,592 | 4,561 | 4,446 | 4,396 | |
| Accounts payable | 475 | 697 | 641 | 671 | 649 | 712 | |
| Accrued liabilities | 123 | 465 | 382 | 357 | 443 | 518 | |
| Deferred revenue | 0.79 | 2.04 | 4.86 | 2.38 | 2.17 | 49.4 | |
| Short-term debt | 20.7 | 51.8 | 97.4 | 223 | 80.1 | 67.3 | |
| Total current liabilities | 690 | 1,371 | 1,461 | 1,717 | 1,569 | 1,494 | |
| Long-term debt | 315 | 1,298 | 1,127 | 845 | 866 | 800 | |
| Lease liabilities | 122 | 306 | 247 | 288 | 281 | 307 | |
| Other non-current liabilities | 18.8 | 105 | 43.4 | 52.3 | 70.3 | 67 | |
| Total liabilities | 1,198 | 3,423 | 3,273 | 3,140 | 3,011 | 2,894 | |
| Total debt | 347 | 1,359 | 1,221 | 1,061 | 893 | 829 | |
| Paid-in capital | 198 | 792 | 795 | 797 | 801 | 804 | |
| Retained earnings | 461 | 413 | 469 | 563 | 657 | 676 | |
| Other comprehensive income | -129 | -126 | -104 | -111 | -166 | -117 | |
| Shareholders' equity | 535 | 1,081 | 1,161 | 1,250 | 1,293 | 1,364 | |
| Minority interests | 123 | 132 | 126 | 137 | 106 | 108 | |
| Total equity | 614 | 658 | 1,213 | 1,287 | 1,387 | 1,399 | 1,472 |
| Total liabilities and equity | 1,886 | 4,668 | 4,592 | 4,561 | 4,446 | 4,396 | |
| Shares outstanding | 411 | 411 | 94.9 | 94.9 | 94.9 | 95 | 95.2 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 69.4 | 71.3 | 17 | 112 | 156 | 143 | 82 |
| Depreciation and amortization | 34.4 | 36.2 | 65.5 | 110 | 104 | 98.8 | 113 |
| Stock-based compensation | 0 | 0 | 0.82 | 4.5 | 6.05 | 7.95 | 6.85 |
| Deferred income tax | -7.97 | -0.7 | -20.9 | -31.1 | -12.6 | -17.6 | 13 |
| Change in receivables | 29.7 | 32.6 | -30.2 | 55.2 | 58.8 | -20.6 | -125 |
| Change in inventory | -6.21 | -18 | -52 | -31.7 | 20.7 | -70.8 | -68 |
| Cash from operations | 75.2 | 145 | 16.4 | 239 | 299 | 263 | 123 |
| Capital expenditures | -27 | -23.2 | -58.6 | -85.6 | -78 | -82.4 | -121 |
| Acquisitions | -4.89 | 0.3 | 104 | -4.89 | -1.26 | -0.93 | -2.25 |
| Purchases of investments | 0 | 0 | -1.21 | -0.46 | -1.15 | -0.26 | |
| Cash from investing | -42 | -25.6 | 82.8 | -66.5 | 5.22 | 35.8 | -19 |
| Debt issued | 386 | 302 | 2,145 | 1,293 | 1,408 | 1,517 | 1,838 |
| Debt repaid | -364 | -2,487 | -1,411 | -1,576 | -1,696 | -1,927 | |
| Stock issued | 0.08 | 0.15 | 7.04 | 0 | 0 | ||
| Dividends paid | -14.9 | -11.9 | -17.1 | -30.4 | -30.4 | -30.6 | -31.6 |
| Cash from financing | -19.8 | -101 | -1.34 | -173 | -230 | -238 | -151 |
| Exchange rate effect | -0.96 | 12.5 | -7.79 | -20.7 | 5.45 | -15.2 | 17.7 |
| Net change in cash | 12.5 | 30.9 | 90.1 | -21.7 | 48.2 | 54.7 | -63.9 |
| Free cash flow | 48.3 | 121 | -42.2 | 153 | 221 | 180 | 1.71 |
| Interest paid | 10.7 | 10.9 | 26.6 | 53.4 | 82.4 | 67.4 | 63.7 |
| Income taxes paid | 16.9 | 19.3 | 26.9 | 50.5 | 64 | 78 | 100 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 7.8% | Gross profit / revenue. |
| Operating margin | 2.4% | Operating income / revenue. |
| EBITDA margin | 3.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.8% | Pre-tax income / revenue. |
| Net margin | 0.6% | Net income / revenue. |
| FCF margin | 0.0% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 1.3% | Cash from operations / revenue. |
| Effective tax rate | 42.2% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 3.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 1.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 6.8% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 0.1% | Research and development expense / revenue. |
| SG&A / revenue | 5.4% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.3% | Capital expenditures / revenue. |
| D&A / revenue | 1.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 8.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 16.1% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -0.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 6.0% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 16.4% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -20.5% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 8.4% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 27.1% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -11.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 5.6% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 26.6% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -59.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -16.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -0.4% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -59.8% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -16.5% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -10.8% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -53.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -19.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -3.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -99.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -77.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -57.4% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 5.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 5.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 20.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -1.1% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -1.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 18.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 11.5% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.17x | Current assets / current liabilities. |
| Quick ratio | 0.54x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.18x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.61x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 18.9% | Total debt / total assets. |
| Liabilities / assets | 65.8% | Total liabilities / total assets. |
| Net debt | $555.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.65x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 3.35x | Operating income / interest expense. |
| Working capital | $257.3M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 17.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $604.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 2.07x | Revenue / average total assets. |
| Fixed asset turnover | 8.33x | Revenue / average property, plant and equipment. |
| Inventory turnover | 18.0x | Cost of revenue / average inventory. |
| Days inventory | 20 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 18.1x | Revenue / average receivables. |
| Days sales outstanding | 20 days | 365 x average receivables / revenue. |
| Days payables | 29 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 11 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 3.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 98.6% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.53 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.54 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $95.65 | Revenue / diluted weighted shares. |
| FCF per share | $0.02 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.28 | Cash from operations / diluted weighted shares. |
| Book value per share | $14.33 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $6.35 | Tangible book value / shares outstanding. |
| Cash per share | $2.88 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 61.5% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 1,847.0% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.23B | Share price x shares outstanding. |
| Enterprise value | $1.78B | Market cap + total debt - cash - short-term investments. |
| P/E | 23.9x | Market cap / net income. Only when net income is positive. |
| P/S | 0.13x | Market cap / revenue. |
| P/B | 0.90x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 2.03x | Market cap / tangible book value, when positive. |
| P/FCF | 717x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 9.95x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.19x | Enterprise value / revenue. |
| EV/EBIT | 7.99x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 5.31x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 1,042x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 0.1% | Free cash flow / market cap. |
| Earnings yield | 4.2% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 2.6% | Dividends paid over the period / market cap. |
| Shareholder yield | 2.6% | (Dividends paid + share buybacks) / market cap. |
What was Dole plc's revenue in fiscal 2025?
Dole plc reported revenue of $9.17B for fiscal 2025, 8.2% higher than the year before.
Was Dole plc profitable in fiscal 2025?
Yes. Net income was $51.3M, a net margin of 0.6%.
How much free cash flow did Dole plc generate in fiscal 2025?
Cash from operations of $123.2M minus capital expenditures of $121.5M left free cash flow of $1.7M.